Medical emergency?Emergency? Call 911. Nearest emergency roomsNearest ERs

Drug company (FDA labeler)

Viatris Specialty LLC

NDC labeler codes: 0037, 49502, 58151

What is a labeler?

The company whose name is on the package and in the FDA’s National Drug Code (NDC) Directory. It may make the medicine itself or sell medicine made by another company. The first part of every NDC code identifies the labeler.

Official FDA data only

Products, approvals and recalls come from the FDA (NDC Directory, Drugs@FDA, enforcement reports). Recalls are linked to this company by the NDC labeler code on the recalled product.

Questions about your medicine: ask your doctor or pharmacist. In an emergency, call 911.

At a glance

109Products (NDC)

Prescription medicines

FDA applications for these products

  • NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
  • ANDA: Abbreviated New Drug Application: how a generic version is approved.
ApprovedApplicationMedicineSponsor
July 28, 2026NDA219990 Norelgestromin and ethinyl estradiol
GWYN LO
Viatris Specialty
August 14, 2019NDA212862 Pretomanid
PRETOMANID
Mylan Ireland Ltd
November 9, 2018NDA210598 Revefenacin
YUPELRI
Mylan Ireland Ltd
March 22, 2018NDA022142 Efavirenz, lamivudine and tenofovir disoproxil fumarate
SYMFI
Mylan Labs Ltd
February 28, 2018NDA022141 Lamivudine and tenofovir disoproxil fumarate
CIMDUO
Mylan Labs Ltd
October 11, 2017NDA209501 Pregabalin
LYRICA CR
Upjohn
March 22, 2013NDA201688 Tobramycin
TOBI PODHALER
Viatris
August 30, 2012NDA203109 Sildenafil
REVATIO
Viatris
May 1, 2012NDA202236 Azelastine hydrochloride and fluticasone propionate
DYMISTA
Mylan Speciality LP
January 4, 2010NDA022488 Pregabalin
LYRICA
Upjohn
November 18, 2009NDA022473 Sildenafil
REVATIO
Viatris
March 13, 2009NDA021997 Zolpidem tartrate
EDLUAR
Viatris
May 11, 2007NDA022007 Formoterol fumarate
PERFOROMIST
Viatris Specialty
December 15, 2006NDA021813 Estradiol
ELESTRIN
Viatris
February 27, 2006NDA021336 Selegiline
EMSAM
Somerset
June 3, 2005NDA021845 Sildenafil
REVATIO
Viatris
February 22, 2005NDA021269 Doxazosin
CARDURA XL
Viatris
December 30, 2004NDA021446 Pregabalin
LYRICA
Upjohn
January 30, 2004NDA021540 Amlodipine and atorvastatin
CADUET
Pharmacia
January 17, 2003NDA021434 Alprazolam
XANAX XR
Upjohn
December 26, 2002NDA021016 Eletriptan hydrobromide
RELPAX
Upjohn
September 27, 2002NDA021437 Eplerenone
INSPRA
Upjohn
June 21, 2002NDA020919 Ziprasidone
GEODON
Viatris
February 5, 2001NDA020825 Ziprasidone
GEODON
Viatris
May 1, 2000NDA021134 Nitroglycerin
NITROSTAT
Viatris
Show the other 27 applications
ApprovedApplicationMedicineSponsor
March 2, 2000NDA021129 Gabapentin
NEURONTIN
Viatris
December 7, 1999NDA020990 Sertraline hydrochloride
ZOLOFT
Viatris
December 31, 1998NDA020998 Celecoxib
CELEBREX
Upjohn
October 9, 1998NDA020882 Gabapentin
NEURONTIN
Viatris
March 27, 1998NDA020895 Sildenafil
VIAGRA
Viatris
March 25, 1998NDA020771 Tolterodine tartrate
DETROL
Upjohn
December 22, 1997NDA050753 Tobramycin
TOBI
Viatris
October 20, 1997NDA020699 Venlafaxine hydrochloride
EFFEXOR XR
Upjohn
December 17, 1996NDA020702 Atorvastatin
LIPITOR
Upjohn
June 5, 1996NDA020597 Latanoprost
XALATAN
Upjohn
February 29, 1996NDA020479 Cromolyn sodium
GASTROCROM
Viatris Specialty
December 30, 1993NDA020235 Gabapentin
NEURONTIN
Viatris
July 29, 1993NDA020189 Felbamate
FELBATOL
Mylan Speciality LP
July 31, 1992NDA019787 Amlodipine
NORVASC
Viatris
December 30, 1991NDA019839 Sertraline hydrochloride
ZOLOFT
Viatris
November 2, 1990NDA019668 Doxazosin
CARDURA
Viatris
July 31, 1990NDA019715 Olsalazine sodium
DIPENTUM
Mylan Spclt Viatris
December 24, 1987NDA019618 Mesalamine
ROWASA, SFROWASA
Mylan Speciality LP
December 22, 1987NDA019430 Epinephrine
EPI E Z PEN JR, EPIPEN, EPIPEN E Z PEN
Viatris
February 12, 1982NDA017351 Hydrocortisone acetate cream
CORTIFOAM
Viatris
October 16, 1981NDA018276 Alprazolam
XANAX
Upjohn
December 19, 1979ANDA086457 Hydrocortisone acetate and pramoxine hydrochloride
EPIFOAM
Mylan Speciality LP
November 8, 1978NDA019854 Penicillamine
DEPEN
Mylan Speciality LP
July 26, 1978ANDA086195 Hydrocortisone acetate and pramoxine hydrochloride
PROCTOFOAM HC
Mylan Speciality LP
August 27, 1976ANDA084349 Phenytoin
DILANTIN
Viatris
April 9, 1959NDA011792 Carisoprodol
SOMA
Mylan Speciality LP
January 6, 1953NDA008762 Phenytoin
DILANTIN-125, DILANTIN-30
Viatris

The sponsor is the company that holds the FDA application; it can differ from the labeler.

Recall timeline

2026

  1. March 17, 2026 · Class II · Ongoing · D-0444-2026 · Alprazolam

    Failed Dissolution Specifications

    Xanax XR, alprazolam, extended-release tablets, 3 mg, 60 Tablets bottles, Rx only, Distributed by: Viatris Specialty LLC, Morgantown, WV 06506, U.S.A, Made in Ireland, NDC 58151-506-91

2024

  1. December 23, 2024 · Class II · Terminated · D-0204-2025 · Doxazosin

    Failed Impurities/Degradation Specifications: Out of specification results observed for the impurity compound B during stability testing.

    Cardura XL (doxazosin) extended release tablets 4 mg, 30 -count bottle, Rx only, Distributed by Viatris Specialty LLC, Morgantown, WV 26505, NDC 58151-078-93

  2. December 23, 2024 · Class II · Terminated · D-0203-2025 · Doxazosin

    Failed Impurities/Degradation Specifications: Out of specification results observed for the impurity compound B during stability testing.

    Cardura XL (doxazosin) extended release tablets 8 mg, 30-count bottle, Rx only, Distributed by Viatris Specialty LLC, Morgantown, WV 26505, NDC 58151-079-93

2022

  1. April 13, 2022 · Class II · Terminated · D-1013-2022 · Epinephrine

    cGMP deviations: Temperature abuse

    Epinephrine Injection, USP, Single-Dose Auto-Injectors 0.3 mg, packaged in 2 count carton, Rx only, MFG: Mylan Pharma, NDC 49502-102-02

  2. April 13, 2022 · Class II · Terminated · D-1014-2022 · Epinephrine

    cGMP deviations: Temperature abuse

    Epinephrine Injection, USP, Single-Dose Auto-Injectors 0.15 mg, packaged in 2 count carton, Rx only, MFG: Mylan Pharma NDC 49502-101-02

  3. April 13, 2022 · Class II · Terminated · D-1012-2022 · Epinephrine

    cGMP deviations: Temperature abuse

    EPI-Pen Jr, 2-PAK, (epinephrine injection, USP) Single-Dose Auto-Injectors 0.15 mg, packaged in 2 count carton, Rx only, MFG: Mylan Pharma, NDC 49502-501-02

  4. April 13, 2022 · Class II · Terminated · D-0993-2022 · Epinephrine

    cGMP deviations: Temperature abuse

    EPI-PEN 2-PAK (epinephrine injection, USP), Single-Dose Auto-Injectors 0.3 mg, Rx only, Manufactured for: Mylan Specialty LP., NDC 49502-500-02

  5. January 21, 2022 · Class II · Terminated · D-0452-2022 · Hydrocortisone acetate and pramoxine hydrochloride

    cGMP deficiencies

    Proctofoam HC (hydrocortisone acetate 1% and pramoxine hydrochloride 1%) topical aerosol, 10 g aerosol containers, Rx Only, Distributed by Meda Pharmaceuticals Inc, Somerset, New Jersey 08873-1120, NDC 0037-6822-10.

2021

  1. March 15, 2021 · Class II · Terminated · D-0528-2021 · Epinephrine

    CGMP Deviations: Intermittent exposure to temperature excursion during storage.

    Epinephrine Injection, USP Auto-Injectors in all strengths, packs and styles Manufactured for Mylan Specialty L.P., Morgantown, WV , NDC: 9502-500-01, 49502-500-02, 49502-500-92, 49502-501-01

  2. March 15, 2021 · Class II · Terminated · D-0529-2021 · Hydrocortisone acetate and pramoxine hydrochloride

    CGMP Deviations: Intermittent exposure to temperature excursion during storage.

    Proctofoam HC (hydrocortisone acetate 1% and pramoxine hydrochloride 1%) topical aerosol 10 g net wt Rx Only NDC 0037-6822-10 Distributed by: Meda Pharmaceutical Inc. Somerset, New Jersey

Show the 4 older recalls

2019

  1. February 1, 2019 · Class II · Terminated · D-0424-2019 · Azelastine hydrochloride and fluticasone propionate

    Defective Container: Potential for broken glass in the neck area of the glass bottles.

    Dymista (azelastine hydrochloride and fluticasone propionate) Nasal Spray, 137 mcg/50 mcg per spray, 120 Metered Sprays, 23 g net fill weight bottle, Rx Only, Manufactured by: Cipla Ltd., Goa, India, M.L. No. 546; For: M

2018

  1. July 25, 2018 · Class II · Terminated · D-1075-2018 · Azelastine hydrochloride and fluticasone propionate

    Presence of foreign substance: Potential for glass in the neck area of the glass bottles.

    Dymista (azelastine hydrochloride and fluticasone propionate) Nasal Spray, 137 mcg / 50 mcg per spray, packaged in a 23 g net fill weight, Rx only, Manufactured by: Cipla Ltd., Goa, India, M.L.,, NDC 0037-0245-23

2017

  1. March 12, 2017 · Class I · Ongoing · D-0691-2017 · Epinephrine

    Defective Delivery System; reports of the device failing to activate which could result in a patient not receiving medication

    EpiPen Jr. 2-Pak (Epinephrine) Auto-Injectors 0.15 mg, Rx only, Manufactured for Mylan Specialty L.P., Morgantown WV 26505 by Meridian Medical Technologies, Inc., Columbia, MD 21046, a Pfizer company; NDC 49502-500-02 --

  2. March 12, 2017 · Class I · Ongoing · D-0690-2017 · Epinephrine

    Defective Delivery System; reports of the device failing to activate which could result in a patient not receiving medication

    EpiPen 2-Pak (Epinephrine) Auto-Injectors 0.3 mg, Rx only, Manufactured for Mylan Specialty L.P., Morgantown WV 26505 by Meridian Medical Technologies, Inc., Columbia, MD 21046, a Pfizer company; NDC 49502-500-02 ---- AL

What do the recall classes mean?

Class I: The most serious type: there is a reasonable chance that using the product will cause serious health problems or death.
Class II: Using the product may cause temporary or medically reversible health problems, or the chance of serious problems is remote.
Class III: Using the product is not likely to cause health problems (for example a labeling or packaging issue).

Sources

  1. NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
  2. Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
  3. Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026

FDA Enforcement Report search → · Report an error →